Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of the RUTI® Vaccine to Prevent SARS-CoV-2 Infection

NCT04453488 is registered in ClinicalTrials.gov with Fundació Institut Germans Trias i Pujol as lead sponsor.

NCT NCT04453488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04453488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Placebo-controlled Clinical Trial to Evaluate the Efficacy of the RUTI® Vaccine to Prevent SARS-CoV-2 Infection
Lead sponsor
Fundació Institut Germans Trias i Pujol
Phase
Phase 3
Overall status
Unknown status
Start date
July 30, 2020
Completion date
December 31, 2020
Enrollment
315 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov2